文献速递系统性红斑狼疮血管炎

QRISK3与颈动脉斑块的相关性在系统性红斑狼疮患者中高于SCORE

QRISK3 relation to carotid plaque is higer than that of score in patients with systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

结果显示QRISK3与颈动脉内中膜厚度显著相关,且对颈动脉斑块的判别能力优于SCORE(AUC 0.765 vs 0.561,P=0.000),SCORE与QRISK3无相关性。结论提示SLE患者心血管风险评估应使用QRISK3而非SCORE。

要点

  • QRISK3对SLE患者颈动脉斑块的判别能力显著优于SCORE(AUC 0.765 vs 0.561)。
  • QRISK3与颈动脉内中膜厚度显著相关(Spearman's rho=0.420,P=0.000),SCORE无此相关性。
  • SLE患者心血管风险评估应使用QRISK3而非SCORE。

核心结论

  • QRISK3对SLE患者亚临床动脉粥样硬化的判别能力高于SCORE。
  • SLE患者心血管风险评估应使用QRISK3而非SCORE。

研究设计与样本

  • 计算QRISK3与SCORE,分析二者之间及与亚临床颈动脉粥样硬化的相关性。

主要发现

  • SCORE与QRISK3在SLE患者中无相关性(Spearman's rho=-0.008,P=0.90)。
  • QRISK3与颈动脉内中膜厚度显著相关(Spearman's rho=0.420,P=0.000),SCORE与颈动脉内中膜厚度无相关性(Spearman's rho=-0.005,P=0.93)。
  • QRISK3对颈动脉斑块的判别能力显著优于SCORE(AUC 0.765 [95%CI: 0.711, 0.820] vs 0.561 [95%CI: 0.494, 0.629],P=0.000)。

临床怎么用

  • 在SLE患者心血管风险评估中应优先使用QRISK3而非SCORE。
  • QRISK3与颈动脉内中膜厚度及颈动脉斑块相关,可用于识别亚临床动脉粥样硬化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: SLE has been described as an independent risk factor for the development of cardiovascular (CV) disease. Recently, the QRESEARCH risk estimator version 3 (QRISK3) calculator has been launched for CV risk assessment in the general population. QRISK3 now includes the presence of SLE as one of its variables for calculating CV risk. Our objective was to compare the predictive capacity between QRISK3 and the Systematic Coronary Risk Evaluation (SCORE) for the presence of subclinical carotid atherosclerosis in patients with SLE. METHODS: Two hundred and ninety-six patients with SLE were recruited. The presence of subclinical atherosclerosis was evaluated by carotid ultrasound to identify carotid plaque and the thickness of the carotid intima-media (cIMT). QRISK3 and SCORE were calculated. The relationship of QRISK3 and SCORE with each other and with the presence of subclinical carotid atherosclerosis (both carotid plaque and cIMT) was studied. RESULTS: There was no correlation between SCORE and QRISK3 in patients with SLE (Spearman's rho = -0.008, P = 0.90). Although QRISK3 showed a statistically significant correlation with cIMT (Spearman's rho = 0.420, P = 0.000), this relationship was not found between SCORE and cIMT (Spearman's rho = -0.005, P = 0.93). The discrimination capacity of QRISK3 for the presence of carotid plaque was statistically significant and superior to that of SCORE (AUC 0.765 [95% CI: 0.711, 0.820] vs 0.561 [95% CI: 0.494, 0.629], P = 0.000). CONCLUSION: QRISK3 discrimination for subclinical atherosclerosis is higher than that of SCORE. QRISK3, and not SCORE, should be used for the calculation of CV risk in patients with SLE.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Quevedo-Abeledo JC, Caceres L, Palazuelos C, et al. QRISK3 relation to carotid plaque is higer than that of score in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2022. PMID: 34240117. doi:10.1093/rheumatology/keab531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。